Vvital Biomed

Vvital Biomed is developing a new transcatheter mitral valve repair (TMVRr) solution that results in a simplified procedure.

Founded December 2016; joined incubator: December 2018
Stage Technology development
Investor The Trendlines Group
CEO Nir Golan

Trendlines’ directors: Steve Rhodes, Barak Singer